Perrigo (PRGO) Notes Payables (2013 - 2026)

Perrigo (PRGO) posted quarterly Notes Payables of $86.9 million for Q3 2015, up 1257.81% quarter-over-quarter from $6.4 million in Q2 2015.

Perrigo (PRGO) Notes Payables (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has reported Notes Payables for 3 consecutive years, with $86.9 million the latest figure, recorded in Q3 2015.

In Q3 2015, Notes Payables changed N/A year-over-year to $86.9 million; the TTM figure through Sep 2015 stood at $86.9 million (changed N/A YoY), while the FY2015 annual figure was $6.4 million, up 204.76% from the prior year.
Notes Payables climbed to $86.9 million in Q3 2015 per PRGO's latest filing, from $6.4 million in the prior quarter.
Across five years, Notes Payables topped out at $86.9 million in Q3 2015 and bottomed at $2.1 million in Q2 2014.
Historically, Notes Payables has averaged $20.8 million across 3 years, with a median of $5.0 million in 2013.
Annual changes were most pronounced in 2014 — Notes Payables slumped 58.0% — and 2015, when it surged 204.76%.
Perrigo's Notes Payables stood at $5.0 million in 2013, then sank by 58.0% to $2.1 million in 2014, then surged by 4038.1% to $86.9 million in 2015.
Business Quant data shows PRGO's Notes Payables at $86.9 million in Q3 2015, $6.4 million in Q2 2015, and $3.4 million in Q1 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	43.07 Bn	39.42 Bn	2.15 Bn
3	Zoetis	31.54 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.19 Bn	19.53 Bn	683.80 Mn
6	Viatris	18.68 Bn	17.79 Bn	1.46 Bn
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-
10	Perrigo	1.93 Bn	1.53 Bn	313.90 Mn

Download Data